Liver metastasis is an important prognostic factor in colorectal cancer. The efficacy of resection of metastatic lesions in liver metastasis of colorectal cancer is also widely recognized. However, studies on treatment methods of unresectable cases have not been sufficient and obtaining complete remission (CR) for liver metastasis is rare with chemotherapy. Selection of reliable chemotherapy for unresectable liver metastasis is an urgent necessity. The usefulness of oxaliplatin, 5-flurouracil and leucovorin combination therapy (FOLFOX) has recently been reported, but CR of liver metastasis is rare. The current status and new therapeutic significance of FOLFOX therapy are discussed based on the literature of colorectal cancer chemotherapy to date, and the clinical experience in which we obtained CR for liver metastasis is reported. The patient had stage IV rectal cancer, perforative peritonitis, pelvic abscess and simultaneous multiple liver metastasis. The patient underwent an emergency operation using the Hartmann's procedure. Liver metastasis is considered to be a prognostic factor and FOLFOX was selected as the postoperative chemotherapy, CR of the liver metastasis was obtained. FOLFOX was suggested to have new clinical significance in oncologic emergencies against unresectable liver metastasis in colorectal cancer and should serve as adjuvant chemotherapy that will contribute to improvement of treatment results.
Benefit of FOLFOX to unresectable liver metastases secondary from colorectal carcinoma in an oncologic emergency. Publishing Authors By Initials
Benefit of FOLFOX to unresectable liver metastases secondary from colorectal carcinoma in an oncologic emergency. Journal Published:
PUBLICATION TYPE: Journal Article
Journal: Hepato-gastroenterology
VOLUME: 54
Page Numbers: 1684-8
Journal Abbreviation: Hepatogastroenterology
ISSN: 0172-6390
DAY: 16
MONTH: Sep
YEAR: 2007
Benefit of FOLFOX to unresectable liver metastases secondary from colorectal carcinoma in an oncologic emergency. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 8007849
Benefit of FOLFOX to unresectable liver metastases secondary from colorectal carcinoma in an oncologic emergency. Keywords Mesh Terms:
KEYWORDS:
MESH TERMS:
Chemical & Substance for Abstract: Benefit of FOLFOX to unresectable liver metastases secondary from colorectal carcinoma in an oncologic emergency. Information
Substance Name:
Registry Number:
Grant and Affiliation Information for Benefit of FOLFOX to unresectable liver metastases secondary from colorectal carcinoma in an oncologic emergency.
AFFILIATION: Department of Surgery, Teikyo University Chiba Medical Center, Chiba, Japan. sugimoto@med.teikyo-u.ac.jp
Country: Greece
AGENCY:
GRANT:
ACRONYM:
MEDLINETA: Hepatogastroenterology
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Benefit of FOLFOX to unresectable liver metastases secondary from colorectal carcinoma in an oncologic emergency Related Publications